Colgate-Palmolive Q3 net sales up 2% to $5.13B, EPS $0.91; announces $200-300M restructuring program

COLGATE PALMOLIVE CO

2025-Q3 EPS reported $2.67 vs consensus $0.92 ▲ beat (+191.8%)

Net sales $5.13B (+2% YoY); organic sales +0.4% reflecting exit of non-strategic pet business.
GAAP EPS $0.91 (+1%); Base Business EPS flat; gross margin decreased 170 bps to 59.4%.
Updated FY2025 organic sales growth guidance; maintained EPS guidance.
New productivity program: $200-300M pre-tax charges (65-75% severance), substantially all incurred by Dec 2028.

item 2.02item 2.05item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.